MedPath

Effect of Nigella Sativa supplement on the expression of genes involved in insulin resistance

Phase 3
Conditions
Obesity.
Overweight and obesity
Registration Number
IRCT20180430039475N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Obese women with BMI between 27 to 35 kg/m2
Age between 25 to 55
Should not use any drug
Should not have diabetes or pre-diabetes or dyslipidemia

Exclusion Criteria

People who smoke or drink alcohol
Pregnant and nursing women
People with chronic kidney, liver disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath